Loading…
Loading grant details…
| Funder | NATIONAL CANCER INSTITUTE |
|---|---|
| Recipient Organization | University of Illinois At Chicago |
| Country | United States |
| Start Date | Jan 25, 2024 |
| End Date | Feb 24, 2029 |
| Duration | 1,857 days |
| Number of Grantees | 1 |
| Roles | Principal Investigator |
| Data Source | NIH (US) |
| Grant ID | 11032070 |
The objective of the “Preclinical PREVENT Cancer Program: Toxicology and Pharmacology Testing” IDIQ contracts will be to continue evaluation of the pharmacological and toxicological effects of potential cancer preventative agents. Resources from these contracts will be used to support development of several candidate cancer preventive agents.
University of Illinois At Chicago
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant